Clinical Trials
10 trialsNCT02908048 2026-05-05
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Terminated
NCT03275974 2026-01-02
Glutamine PET Imaging Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT03956056 2024-07-17
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Washington University School of Medicine
Phase 1 Terminated
NCT03108885 2024-03-22
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Mayo Clinic
Terminated
NCT03172403 2022-08-25
MYOCAC
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Terminated
NCT04264754 2021-05-06
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Nucleix Ltd.
Terminated
NCT01547923 2020-03-25
DPD côlon
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT01521780 2015-11-02
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT01227018 2014-07-23
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT00539318 2009-08-14
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Terminated